Conditions

Raised PSA

Understanding an elevated PSA result and what it means for you

What is PSA and why is it measured?

PSA (prostate-specific antigen) is a protein produced by cells of the prostate gland. Small amounts enter the bloodstream, where they can be measured with a simple blood test. PSA is not a cancer marker — it is a prostate marker. It rises whenever the prostate gland is inflamed, enlarged, or disturbed, regardless of the cause.

PSA testing is used to identify men who may benefit from further investigation for prostate cancer, because many early prostate cancers do not cause symptoms. However, an elevated PSA requires careful interpretation rather than an automatic response.

What can cause a raised PSA?

The most common reasons for an elevated PSA include:

  • Benign prostatic hyperplasia (BPH) — a non-cancerous enlargement of the prostate; a larger prostate produces more PSA
  • Prostatitis — inflammation or infection of the prostate, which can acutely raise PSA by a significant amount
  • Urinary tract infection — may temporarily elevate PSA
  • Recent ejaculation or vigorous physical activity — can cause a short-lived rise
  • Prostate cancer — particularly clinically significant cancer, which typically produces a disproportionate PSA rise relative to prostate size

Understanding the likely cause guides the appropriate response.

What happens next

Confirming the result

A single raised PSA result is usually repeated after a few weeks, avoiding any factors that may have temporarily elevated the level. If the result remains elevated, further investigation is recommended.

Multiparametric MRI (mpMRI)

An MRI of the prostate is now recommended before proceeding to biopsy. The scan assesses the internal architecture of the prostate and assigns a PIRADS score (1–5) to any suspicious areas. This information helps determine whether a biopsy is warranted and, if so, which areas should be sampled.

Prostate biopsy

A biopsy is recommended when the MRI shows a suspicious lesion (PIRADS 3, 4, or 5) and the PSA level or other features support sufficient clinical concern. The preferred method is a transperineal biopsy under anaesthesia, which combines systematic sampling with targeted sampling of MRI-suspicious areas.

Watchful waiting

If the MRI is reassuring (PIRADS 1 or 2) and the PSA is only mildly elevated, active surveillance with regular PSA checks and repeat MRI is often the most appropriate approach.

Making sense of your result

A raised PSA result can be unsettling, but the majority of men investigated for raised PSA do not have prostate cancer. The investigation pathway is designed to identify those who do have a clinically significant cancer — one that requires treatment — while avoiding unnecessary procedures in those who do not.

Following a structured evaluation — repeat PSA, mpMRI, and biopsy where indicated — gives a reliable picture of whether prostate cancer is present, and if so, its nature and likely behaviour. This information is the basis for all subsequent decisions, whether that involves active surveillance, treatment, or simply reassurance and monitoring.

Frequently Asked Questions

Need an assessment?

To arrange an appointment or discuss your situation, please contact the secretary.

Contact us
Call the Secretary — 22 444 444